Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Healthcare Stocks Are Falling This Week

By Todd Campbell – Sep 22, 2020 at 1:45PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Justice Ruth Bader Ginsburg's death jeopardizes Obamacare's future, and that puts healthcare companies' revenue at risk.

The future of Obamacare became murkier this week with the passing of longtime Supreme Court Justice Ruth Bader Ginsburg, who affirmed the constitutionality of various parts of the Affordable Care Act (ACA) in numerous of rulings.

If Ginsburg's replacement sides with Supreme Court conservatives against the ACA in an upcoming case, the number of Americans without health insurance could rise by millions, which would cause revenue to fall for healthcare companies. Currently, more than 20 million Americans have health insurance because of Obamacare.

A view of the front of the building housing the Supreme Court.

IMAGE SOURCE: GETTY IMAGES.

The possibility that fewer people would seek necessary medical care if Obamacare is dismantled sent share prices for health insurers, medical device companies, and biopharma companies tumbling on Monday.

The Health Care Select Sector SPDR Fund (XLV -0.54%) and SPDR S&P Biotech ETF (XBI 0.55%) dropped by 2.2% and 3.6%, respectively, and declines were bigger for many individual healthcare stocks. For instance, hospital giant HCA Healthcare (HCA 1.27%) declined by 5.1% and Medicaid-insurer Centene (CNC -0.34%) fell by 8.4%.

Since the ACA became law in 2010, Republicans have sought to dismantle it via a number of means, including a series of legal challenges in the Supreme Court. So far, results there have been mixed. The Supreme Court struck down a rule mandating states expand Medicaid coverage, but concluded that the individual health insurance mandate was constitutional in 2012, a decision that largely kept Obamacare intact.

That could change on Nov. 10, when the Supreme Court is scheduled to begin hearing oral arguments regarding Republicans' latest challenge to the individual mandate. 

In 2017, the Tax Cuts and Jobs Act reduced the penalty associated with forgoing health insurance to zero. Because the majority opinion in 2012 cited the mandate's constitutionality under the federal government's taxing authority, and no penalty is now assessed for failing to have health insurance, the law's constitutionality is being reexamined.

Todd Campbell has no position in any of the stocks mentioned. His clients may have positions in the companies mentioned. The Motley Fool recommends HCA Healthcare. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Health Care SPDR Stock Quote
Health Care SPDR
XLV
$135.38 (-0.54%) $0.73
HCA Healthcare Stock Quote
HCA Healthcare
HCA
$237.33 (1.27%) $2.98
Centene Stock Quote
Centene
CNC
$84.64 (-0.34%) $0.29
SPDR S&P Biotech Stock Quote
SPDR S&P Biotech
XBI
$80.09 (0.55%) $0.44

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.